Critical Care
p. 429
A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care.
Longo, C. J.; Heyland, D. K.; Fisher, H. N.; Fowler, R. A.; Martin, C. M.; Day, A. G.
http://zetoc.mimas.ac.uk/wzgw?db=etoc&terms=PM018983692&field=zid
No comments:
Post a Comment